Uncovering novel susceptibility targets to enhance the efficacy of third-generation cephalosporins against ESBL-producing uropathogenic Escherichia coli.

MLA

Phan, Minh-Duy, et al. “Uncovering Novel Susceptibility Targets to Enhance the Efficacy of Third-Generation Cephalosporins against ESBL-Producing Uropathogenic Escherichia Coli.” Journal of Antimicrobial Chemotherapy (JAC), vol. 75, no. 6, June 2020, pp. 1415–23. EBSCOhost, https://doi.org/10.1093/jac/dkaa023.

APA

Phan, M.-D., Bottomley, A. L., Peters, K. M., Harry, E. J., & Schembri, M. A. (2020). Uncovering novel susceptibility targets to enhance the efficacy of third-generation cephalosporins against ESBL-producing uropathogenic Escherichia coli. Journal of Antimicrobial Chemotherapy (JAC), 75(6), 1415–1423. https://doi.org/10.1093/jac/dkaa023

Chicago

Phan, Minh-Duy, Amy L Bottomley, Kate M Peters, Elizabeth J Harry, and Mark A Schembri. 2020. “Uncovering Novel Susceptibility Targets to Enhance the Efficacy of Third-Generation Cephalosporins against ESBL-Producing Uropathogenic Escherichia Coli.” Journal of Antimicrobial Chemotherapy (JAC) 75 (6): 1415–23. doi:10.1093/jac/dkaa023.